Cymbalta
(Duloxetine)
Cymbalta is an SNRI that treats both mood and pain. It is one of the few antidepressants FDA-approved for chronic pain conditions like fibromyalgia and diabetic neuropathy, in addition to depression and anxiety.
Most patients pay less than $20 per appointment.
Cymbalta is a strong option for people whose depression or anxiety comes alongside chronic pain, fatigue, or physical symptoms. Its active ingredient, duloxetine, acts on both serotonin and norepinephrine pathways, giving it a broader reach than a standard SSRI.
Getting help shouldn’t be hard.
Book a free 15-minute consult
Tell us a little about yourself — no pressure, no commitment. Just a conversation.
Meet your psychiatrist
Connect with a licensed provider via video or in person in Texas.
Attend weekly sessions
Flexible, personalised psychiatric care tailored to your life.
Meet the psychiatrists you'll actually talk to.
Board-certified psychiatrists with deep expertise in LGBTQ+ mental health and medication management.
Komal Nathani
Komal is an LGBTQ+ affirming psychiatrist who works with queer, trans, and gender-expansive adolescents and adults navigating anxiety, depression, ADHD, trauma, and identity. She offers a space where your full self is welcome, and brings real understanding to the intersection of queerness, culture, and mental health.
MD PsychiatristAdam Butera
Adam is an LGBTQ+ affirming psychiatrist with 23 years in private practice, offering care for depression, bipolar disorder, anxiety, PTSD, OCD, addiction, and ADHD. He takes time to understand each person as a whole human being, working with adolescents, adults, and seniors across diverse backgrounds.
MD PsychiatristReal questions. Honest answers.
-
Cymbalta (duloxetine) is FDA-approved for major depression, generalised anxiety disorder, diabetic peripheral neuropathy, fibromyalgia, and chronic musculoskeletal pain.
-
Yes — this is one of Cymbalta's distinguishing features. It is particularly effective for nerve pain, fibromyalgia, and lower back pain, alongside mood symptoms.
-
Nausea is the most frequent side effect, especially in the first 1–2 weeks. Others include dry mouth, fatigue, sweating, and constipation.
-
Cymbalta is not recommended for people with significant liver disease. Share your full medical history with your psychiatrist.
-
Cymbalta should never be stopped abruptly. A gradual taper under medical supervision is essential to avoid discontinuation symptoms.
-
Both are SNRIs, but Cymbalta has more evidence for pain management and is sometimes preferred when chronic pain accompanies mood symptoms.
-
Depression and anxiety symptoms typically improve within 4–6 weeks. Pain relief may come sooner — sometimes within the first couple of weeks.
-
Book a free consult at Outspace. Our psychiatrists will assess whether Cymbalta is the right fit for your full symptom picture.